← FDA Drug Approvals (Drugs@FDA)
BUPIVACAINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2016-07-25
Drug application
- FDA Application #
ANDA207266- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BUPIVACAINE HYDROCHLORIDE
- Generic name
- Bupivacaine Hydrochloride
- Active ingredients
- BUPIVACAINE HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- SPINAL
- Marketing status
- Discontinued
- Sponsor
- BAXTER HLTHCARE CORP
- First approval
- 2016-07-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown